Plain-English translation of NCT06902519 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new medication called to see if it is safe and well-tolerated in people with rheumatoid arthritis. The study will also measure how the medication is absorbed, processed, and cleared by your body when taken multiple times over several weeks. Researchers want to understand whether this treatment could eventually help people with rheumatoid arthritis manage their condition.
Rheumatoid arthritis can be difficult to control, and some people don't respond well to existing treatments or experience side effects. This trial exists to evaluate whether this medication could become a new option for people who need better disease management.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be randomly assigned to receive either the new medication or a placebo (a dummy pill with no active ingredient) for up to 12 weeks. During this time, you will have study visits where researchers will check your safety through blood tests and physical exams, and monitor how well the treatment is working. You will continue taking your regular rheumatoid arthritis medications during the study.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States